{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:28:28Z","timestamp":1793741308642,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To critically appraise the evidence for and against premonitory symptoms in migraine being due to hypothalamic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Some premonitory symptoms (e.g. fatigue, mood changes, yawning, and food craving) are associated with the physiologic effects of neurotransmitters such as orexins, neuropeptide Y, and dopamine; all of which are expressed in hypothalamic neurons. In rodents, electrophysiologic recordings have shown that these neurotransmitters modulate nociceptive transmission at the level of second-order neurons in the trigeminocervical complex (TCC). Additional insights have been gained from neuroimaging studies that report hypothalamic activation during the premonitory phase of migraine. However, the available evidence is limited by methodologic issues, inconsistent reporting, and a lack of adherence to ICHD definitions of premonitory symptoms (or prodromes) in human experimental studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The current trend to accept that premonitory symptoms are due to hypothalamic dysfunction might be premature. More rigorously designed studies are needed to ascertain whether the neurobiologic basis of premonitory symptoms is due to hypothalamic dysfunction or rather reflects modulatory input to the trigeminovascular system from several cortical and subcortical areas. On a final note, the available epidemiologic data raises questions as to whether the existence of premonitory symptoms and even more so a distinct premonitory phase is a true migraine phenomenon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>\n                      Video recording of the debate held at the 1st International Conference on Advances in Migraine Sciences (ICAMS 2022, Copenhagen, Denmark) is available at:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.youtube.com\/watch?v=d4Y2x0Hr4Q8\">https:\/\/www.youtube.com\/watch?v=d4Y2x0Hr4Q8<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-022-01518-5","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T04:03:08Z","timestamp":1670904188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence"],"prefix":"10.1186","volume":"23","author":[{"given":"Cedric","family":"Gollion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"De Icco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"1518_CR1","unstructured":"Ashina M. Migraine. N Engl J Med [Internet]. 2020 Nov 4 [cited 2021 Mar 10]; Available from: https:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMra1915327"},{"key":"1518_CR2","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia Int J Headache. 2018;38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"4","key":"1518_CR3","first-page":"221","volume":"12","author":"BK Rasmussen","year":"1992","unstructured":"Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia Int. J Headache 12(4):221\u2013228 discussion 186","journal-title":"J Headache"},{"issue":"4","key":"1518_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1468-2982.1996.1604239.x","volume":"16","author":"MB Russell","year":"1996","unstructured":"Russell MB, Rasmussen BK, Fenger K, Olesen J (1996) Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia Int J Headache 16(4):239\u2013245","journal-title":"Cephalalgia Int J Headache"},{"issue":"4","key":"1518_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1526-4610.2002.02080.x","volume":"42","author":"H Kececi","year":"2002","unstructured":"Kececi H, Dener S (2002) Epidemiological and clinical characteristics of migraine in Sivas. Turkey Headache 42(4):275\u2013280","journal-title":"Turkey Headache"},{"issue":"7","key":"1518_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/AJP.0000000000000301","volume":"32","author":"B Baykan","year":"2016","unstructured":"Baykan B, Ekizoglu E, Karli N, Kocasoy-Orhan E, Zarifoglu M, Saip S et al (2016) Characterization of Migraineurs having allodynia: results of a large population-based study. Clin J Pain 32(7):631\u2013635","journal-title":"Clin J Pain"},{"issue":"4","key":"1518_CR7","first-page":"339","volume":"5","author":"G Santoro","year":"1990","unstructured":"Santoro G, Bernasconi F, Sessa F, Venco A (1990) Premonitory symptoms in migraine without aura: a clinical investigation. Funct Neurol 5(4):339\u2013344","journal-title":"Funct Neurol"},{"issue":"6","key":"1518_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1468-2982.2005.00880.x","volume":"25","author":"N Karli","year":"2005","unstructured":"Karli N, Zarifoglu M, Calisir N, Akgoz S (2005) Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia Int J Headache 25(6):444\u2013451","journal-title":"Cephalalgia Int J Headache"},{"issue":"7","key":"1518_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1526-4610.2006.00444.x","volume":"46","author":"L Kelman","year":"2006","unstructured":"Kelman L (2006) Migraine changes with age: IMPACT on migraine classification. Headache 46(7):1161\u20131171","journal-title":"Headache"},{"issue":"9","key":"1518_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1468-2982.2006.01157.x","volume":"26","author":"E Quintela","year":"2006","unstructured":"Quintela E, Castillo J, Mu\u00f1oz P, Pascual J (2006) Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia Int J Headache 26(9):1051\u20131060","journal-title":"Cephalalgia Int J Headache"},{"issue":"10","key":"1518_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1468-2982.2006.01195.x","volume":"26","author":"GG Schoonman","year":"2006","unstructured":"Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD (2006) The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia Int J Headache 26(10):1209\u20131213","journal-title":"Cephalalgia Int J Headache"},{"issue":"16","key":"1518_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10194-015-0495-7","volume":"15","author":"LH Schulte","year":"2015","unstructured":"Schulte LH, J\u00fcrgens TP, May A (2015) Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers? J Headache Pain 15(16):14","journal-title":"J Headache Pain"},{"issue":"10","key":"1518_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/0333102415620251","volume":"36","author":"K Laurell","year":"2016","unstructured":"Laurell K, Artto V, Bendtsen L, Hagen K, H\u00e4ggstr\u00f6m J, Linde M et al (2016) Premonitory symptoms in migraine: a cross-sectional study in 2714 persons. Cephalalgia Int J Headache 36(10):951\u2013959","journal-title":"Cephalalgia Int J Headache"},{"issue":"9","key":"1518_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/0333102415613612","volume":"36","author":"M Viana","year":"2016","unstructured":"Viana M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G et al (2016) Variability of the characteristics of a migraine attack within patients. Cephalalgia Int J Headache 36(9):825\u2013830","journal-title":"Cephalalgia Int J Headache"},{"issue":"2","key":"1518_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/head.13195","volume":"58","author":"B G\u00fcven","year":"2018","unstructured":"G\u00fcven B, G\u00fcven H, \u00c7omo\u011flu SS (2018) Migraine and yawning. Headache 58(2):210\u2013216","journal-title":"Headache"},{"issue":"6","key":"1518_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0333102418815505","volume":"39","author":"TJ Schwedt","year":"2019","unstructured":"Schwedt TJ, Peplinski J, Garcia-Filion P, Berisha V (2019) Altered speech with migraine attacks: a prospective, longitudinal study of episodic migraine without aura. Cephalalgia Int J Headache 39(6):722\u2013731","journal-title":"Cephalalgia Int J Headache"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/JPR.S175602","volume":"11","author":"AB Gago-Veiga","year":"2018","unstructured":"Gago-Veiga AB, Pag\u00e1n J, Henares K, Heredia P, Gonz\u00e1lez-Garc\u00eda N, De Orbe MI et al (2018) To what extent are patients with migraine able to predict attacks? J Pain Res 11:2083\u20132094","journal-title":"J Pain Res"},{"issue":"9","key":"1518_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0333102421997850","volume":"41","author":"X Wang","year":"2021","unstructured":"Wang X, Yin Z, Lian Y, Xu Y, Li Y, Liu J et al (2021) Premonitory symptoms in migraine from China: a multi-clinic study of 4821 patients. Cephalalgia Int J Headache 41(9):991\u20131003","journal-title":"Cephalalgia Int J Headache"},{"key":"1518_CR19","doi-asserted-by":"crossref","unstructured":"Eigenbrodt AK, Christensen RH, Ashina H, Iljazi A, Christensen CE, Steiner TJ, Lipton RB, Ashina M. Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency. J Headache Pain. 2022;23(1):140.","DOI":"10.1186\/s10194-022-01510-z"},{"issue":"3","key":"1518_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/WCO.0000000000001065","volume":"35","author":"D Martinelli","year":"2022","unstructured":"Martinelli D, Pocora MM, De Icco R, Putort\u00ec A, Tassorelli C (2022) Triggers of migraine: where do we stand? Curr Opin Neurol 35(3):360\u2013366","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 1","key":"1518_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A phase-by-phase review of Migraine pathophysiology. Headache 58(Suppl 1):4\u201316","journal-title":"Headache"},{"issue":"2","key":"1518_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of Migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"issue":"10","key":"1518_CR23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/head.12468","volume":"54","author":"JM Pavlovic","year":"2014","unstructured":"Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB (2014) Trigger factors and premonitory features of migraine attacks: summary of studies. Headache 54(10):1670\u20131679","journal-title":"Headache"},{"issue":"10","key":"1518_CR24","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/head.12464","volume":"54","author":"RB Lipton","year":"2014","unstructured":"Lipton RB, Pavlovic JM, Haut SR, Grosberg BM, Buse DC (2014) Methodological issues in studying trigger factors and premonitory features of migraine. Headache 54(10):1661\u20131669","journal-title":"Headache"},{"issue":"13","key":"1518_CR25","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1177\/0333102419883375","volume":"39","author":"LH Schulte","year":"2019","unstructured":"Schulte LH, Peng KP (2019) Current understanding of premonitory networks in migraine: a window to attack generation. Cephalalgia 39(13):1720\u20131727","journal-title":"Cephalalgia"},{"issue":"12","key":"1518_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41582-018-0098-4","volume":"14","author":"N Karsan","year":"2018","unstructured":"Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol 14(12):699\u2013710","journal-title":"Nat Rev Neurol"},{"key":"1518_CR27","unstructured":"Headache classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia Int J Headache. 1988; 8(Suppl 7):1\u201396."},{"key":"1518_CR28","unstructured":"Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd. Cephalalgia Int J Headache. 2004;24 Suppl 1:9\u2013160."},{"key":"1518_CR29","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia Int J Headache 2013;33(9):629\u2013808","DOI":"10.1177\/0333102413485658"},{"issue":"6","key":"1518_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1526-4610.2007.00842.x","volume":"47","author":"P Holland","year":"2007","unstructured":"Holland P, Goadsby PJ (2007) The hypothalamic orexinergic system: pain and primary headaches. Headache 47(6):951\u2013962","journal-title":"Headache"},{"issue":"1770","key":"1518_CR31","doi-asserted-by":"publisher","first-page":"147629","DOI":"10.1016\/j.brainres.2021.147629","volume":"1","author":"M Martins-Oliveira","year":"2021","unstructured":"Martins-Oliveira M, Tavares I, Goadsby PJ (2021) Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits. Brain Res 1(1770):147629","journal-title":"Brain Res"},{"issue":"3","key":"1518_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.pain.2004.02.005","volume":"109","author":"T Bartsch","year":"2004","unstructured":"Bartsch T, Levy MJ, Knight YE, Goadsby PJ (2004) Differential modulation of nociceptive dural input to [hypocretin] orexin a and B receptor activation in the posterior hypothalamic area. Pain 109(3):367\u2013378","journal-title":"Pain"},{"issue":"10","key":"1518_CR33","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1111\/j.1460-9568.2006.05168.x","volume":"24","author":"PR Holland","year":"2006","unstructured":"Holland PR, Akerman S, Goadsby PJ (2006) Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci 24(10):2825\u20132833","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1518_CR34","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1124\/jpet.105.090951","volume":"315","author":"PR Holland","year":"2005","unstructured":"Holland PR, Akerman S, Goadsby PJ (2005) Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 315(3):1380\u20131385","journal-title":"J Pharmacol Exp Ther"},{"key":"1518_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2014.10.022","volume":"74","author":"J Hoffmann","year":"2015","unstructured":"Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J et al (2015) Evidence for orexinergic mechanisms in migraine. Neurobiol Dis 74:137\u2013143","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1518_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0196-9781(92)90084-G","volume":"13","author":"I Jansen","year":"1992","unstructured":"Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L (1992) Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13(3):527\u2013536","journal-title":"Peptides"},{"issue":"2","key":"1518_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1476-5381.1996.tb15975.x","volume":"119","author":"XJ Yu","year":"1996","unstructured":"Yu XJ, Moskowitz MA (1996) Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br J Pharmacol 119(2):229\u2013232","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1518_CR38","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1097\/j.pain.0000000000000571","volume":"157","author":"MM Oliveira","year":"2016","unstructured":"Oliveira MM, Akerman S, Tavares I, Goadsby PJ (2016) Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine. Pain 157(8):1666\u20131673","journal-title":"Pain"},{"issue":"40","key":"1518_CR39","doi-asserted-by":"publisher","first-page":"12532","DOI":"10.1523\/JNEUROSCI.2887-09.2009","volume":"29","author":"AR Charbit","year":"2009","unstructured":"Charbit AR, Akerman S, Holland PR, Goadsby PJ (2009) Neurons of the dopaminergic\/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the Trigeminocervical complex: an electrophysiological and Immunohistochemical study. J Neurosci 29(40):12532\u201312541","journal-title":"J Neurosci"},{"issue":"2","key":"1518_CR40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1124\/jpet.109.151951","volume":"331","author":"AR Charbit","year":"2009","unstructured":"Charbit AR, Akerman S, Goadsby PJ (2009) Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. J Pharmacol Exp Ther 331(2):752\u2013763","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1518_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.21077","volume":"61","author":"A Bergerot","year":"2007","unstructured":"Bergerot A, Storer RJ, Goadsby PJ (2007) Dopamine inhibits trigeminovascular transmission in the rat. Ann Neurol 61(3):251\u2013262","journal-title":"Ann Neurol"},{"issue":"4","key":"1518_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/j.pain.0000000000000091","volume":"156","author":"K Abdallah","year":"2015","unstructured":"Abdallah K, Monconduit L, Artola A, Luccarini P, Dallel R (2015) GABAAergic inhibition or dopamine denervation of the A11 hypothalamic nucleus induces trigeminal analgesia. Pain 156(4):644\u2013655","journal-title":"Pain"},{"issue":"5","key":"1518_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0333102414544979","volume":"35","author":"A Chabi","year":"2015","unstructured":"Chabi A, Zhang Y, Jackson S, Cady R, Lines C, Herring WJ et al (2015) Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia Int J Headache 35(5):379\u2013388","journal-title":"Cephalalgia Int J Headache"},{"key":"1518_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2015.03.006","volume":"52","author":"J Tajti","year":"2015","unstructured":"Tajti J, Szok D, Majl\u00e1th Z, Tuka B, Cs\u00e1ti A, V\u00e9csei L (2015) Migraine and neuropeptides. Neuropeptides 52:19\u201330","journal-title":"Neuropeptides"},{"issue":"4","key":"1518_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/ana.410200409","volume":"20","author":"I Jansen","year":"1986","unstructured":"Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J et al (1986) Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 20(4):496\u2013501","journal-title":"Ann Neurol"},{"issue":"2\u20133","key":"1518_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0165-1838(99)00024-7","volume":"76","author":"J Tajti","year":"1999","unstructured":"Tajti J, Uddman R, M\u00f6ller S, Sundler F, Edvinsson L (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76(2\u20133):176\u2013183","journal-title":"J Auton Nerv Syst"},{"issue":"3","key":"1518_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/WCO.0b013e3283378d5c","volume":"23","author":"AR Charbit","year":"2010","unstructured":"Charbit AR, Akerman S, Goadsby PJ (2010) Dopamine: what\u2019s new in migraine? Curr Opin Neurol 23(3):275\u2013281","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"1518_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","volume":"60","author":"SD Silberstein","year":"2003","unstructured":"Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS (2003) Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 60(2):315\u2013321","journal-title":"Neurology"},{"issue":"7479","key":"1518_CR49","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/bmj.38281.595718.7C","volume":"329","author":"I Colman","year":"2004","unstructured":"Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2004 18;bmj;bmj.38281.595718.7Cv1) Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 329(7479):1369","journal-title":"BMJ"},{"issue":"3","key":"1518_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ajem.2014.11.013","volume":"33","author":"C Eken","year":"2015","unstructured":"Eken C (2015) Critical reappraisal of intravenous metoclopramide in migraine attack: a systematic review and meta-analysis. Am J Emerg Med 33(3):331\u2013337","journal-title":"Am J Emerg Med"},{"key":"1518_CR51","first-page":"CD008041","volume":"4","author":"V Kirthi","year":"2010","unstructured":"Kirthi V, Derry S, Moore RA, McQuay HJ (2010) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008041","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"1518_CR52","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1526-4610.2007.00776.x","volume":"47","author":"M Denuelle","year":"2007","unstructured":"Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G (2007) Hypothalamic activation in spontaneous migraine attacks. Headache 47(10):1418\u20131426","journal-title":"Headache"},{"issue":"Pt 7","key":"1518_CR53","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/aww097","volume":"139","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, May A (2016) The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain J Neurol 139(Pt 7):1987\u20131993","journal-title":"Brain J Neurol"},{"issue":"4","key":"1518_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.25697","volume":"87","author":"LH Schulte","year":"2020","unstructured":"Schulte LH, Mehnert J, May A (2020) Longitudinal neuroimaging over 30\u2009days: temporal characteristics of Migraine. Ann Neurol 87(4):646\u2013651","journal-title":"Ann Neurol"},{"issue":"12","key":"1518_CR55","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1097\/j.pain.0000000000001676","volume":"160","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Park BY, Cho S, Park H, Kim ST, Chung CS (2019) Dynamic functional connectivity of the migraine brain: a resting-state functional magnetic resonance imaging study. Pain 160(12):2776\u20132786","journal-title":"Pain"},{"issue":"6","key":"1518_CR56","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/hbm.24030","volume":"39","author":"N Meylakh","year":"2018","unstructured":"Meylakh N, Marciszewski KK, Pietro FD, Macefield VG, Macey PM, Henderson LA (2018) Deep in the brain: changes in subcortical function immediately preceding a migraine attack. Hum Brain Mapp 39(6):2651\u20132663","journal-title":"Hum Brain Mapp"},{"issue":"Pt 1","key":"1518_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ (2014) Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain J Neurol 137(Pt 1):232\u2013241","journal-title":"Brain J Neurol"},{"issue":"7","key":"1518_CR58","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/head.13865","volume":"60","author":"N Karsan","year":"2020","unstructured":"Karsan N, Bose PR, O\u2019Daly O, Zelaya FO, Goadsby PJ (2020) Alterations in functional connectivity during different phases of the triggered Migraine attack. Headache 60(7):1244\u20131258","journal-title":"Headache"},{"issue":"3","key":"1518_CR59","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1111\/ejn.15369","volume":"54","author":"WPJ van Oosterhout","year":"2021","unstructured":"van Oosterhout WPJ, van Opstal AM, Schoonman GG, van der Grond J, Terwindt GM, Ferrari MD et al (2021) Hypothalamic functional MRI activity in the initiation phase of spontaneous and glyceryl trinitrate-induced migraine attacks. Eur J Neurosci 54(3):5189\u20135202","journal-title":"Eur J Neurosci"},{"issue":"15","key":"1518_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1129-2377-15-84","volume":"3","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C, Goadsby PJ (2014) The origin of nausea in migraine-a PET study. J Headache Pain 3(15):84","journal-title":"J Headache Pain"},{"issue":"2","key":"1518_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/brainsci11020165","volume":"11","author":"D Martinelli","year":"2021","unstructured":"Martinelli D, Castellazzi G, De Icco R, Bacila A, Allena M, Faggioli A et al (2021) Thalamocortical connectivity in experimentally-induced Migraine attacks: a pilot study. Brain Sci 11(2):165","journal-title":"Brain Sci"},{"issue":"49","key":"1518_CR62","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1523\/JNEUROSCI.1088-18.2018","volume":"38","author":"KK Marciszewski","year":"2018","unstructured":"Marciszewski KK, Meylakh N, Di Pietro F, Mills EP, Macefield VG, Macey PM et al (2018) Changes in brainstem pain modulation circuitry function over the Migraine cycle. J Neurosci 38(49):10479\u201310488","journal-title":"J Neurosci"},{"issue":"11","key":"1518_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fneur.2020.00140","volume":"25","author":"N Karsan","year":"2020","unstructured":"Karsan N, Goadsby PJ (2020) Imaging the premonitory phase of Migraine. Front Neurol 25(11):140","journal-title":"Front Neurol"},{"issue":"3","key":"1518_CR64","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pain.2004.05.007","volume":"110","author":"KS Afridi","year":"2004","unstructured":"Afridi KS, Kaube H, Goadsby JP (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 110(3):675\u2013680","journal-title":"Pain"},{"issue":"9","key":"1518_CR65","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1097\/j.pain.0000000000001894","volume":"161","author":"GLJ Onderwater","year":"2020","unstructured":"Onderwater GLJ, Dool J, Ferrari MD, Terwindt GM (2020) Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study. Pain 161(9):2058\u20132067","journal-title":"Pain"},{"issue":"8","key":"1518_CR66","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/0333102420910114","volume":"40","author":"N Karsan","year":"2020","unstructured":"Karsan N, Bose PR, Thompson C, Newman J, Goadsby PJ (2020) Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: a human pharmacological triggering study. Cephalalgia Int J Headache 40(8):828\u2013841","journal-title":"Cephalalgia Int J Headache"},{"issue":"12","key":"1518_CR67","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M, Hansen JM, Dunga \u00c1, BO, Olesen J. (2017) Human models of migraine - short-term pain for long-term gain. Nat Rev Neurol 13(12):713\u2013724","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"1518_CR68","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","volume":"60","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al (2003) Premonitory symptoms in migraine: an electronic diary study. Neurology 60(6):935\u2013940","journal-title":"Neurology"},{"issue":"2","key":"1518_CR69","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/0028-3886.227302","volume":"66","author":"S Pradhan","year":"2018","unstructured":"Pradhan S, Choudhury SS (2018) Clinical characterization of neck pain in migraine. Neurol India 66(2):377\u2013384","journal-title":"Neurol India"},{"issue":"1","key":"1518_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s10194-019-0991-2","volume":"20","author":"C Lampl","year":"2019","unstructured":"Lampl C, Rapoport A, Levin M, Br\u00e4utigam E (2019) Migraine and episodic Vertigo: a cohort survey study of their relationship. J Headache Pain 20(1):33","journal-title":"J Headache Pain"},{"issue":"6","key":"1518_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0333102420975401","volume":"41","author":"N Karsan","year":"2021","unstructured":"Karsan N, Per\u00e9z-Rodr\u00edguez A, Nagaraj K, Bose PR, Goadsby PJ (2021) The migraine postdrome: spontaneous and triggered phenotypes. Cephalalgia Int J Headache 41(6):721\u2013730","journal-title":"Cephalalgia Int J Headache"},{"issue":"3","key":"1518_CR72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0333102414535110","volume":"35","author":"S Ashina","year":"2015","unstructured":"Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R (2015) Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia Int J Headache 35(3):211\u2013219","journal-title":"Cephalalgia Int J Headache"},{"issue":"9","key":"1518_CR73","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/ene.12451","volume":"21","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C, Goadsby PJ (2014) Photic hypersensitivity in the premonitory phase of migraine--a positron emission tomography study. Eur J Neurol 21(9):1178\u20131183","journal-title":"Eur J Neurol"},{"issue":"5","key":"1518_CR74","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0333102420911623","volume":"40","author":"N Meylakh","year":"2020","unstructured":"Meylakh N, Marciszewski KK, Di Pietro F, Macefield VG, Macey PM, Henderson LA (2020) Altered regional cerebral blood flow and hypothalamic connectivity immediately prior to a migraine headache. Cephalalgia Int J Headache 40(5):448\u2013460","journal-title":"Cephalalgia Int J Headache"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01518-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01518-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01518-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T16:54:36Z","timestamp":1701536076000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01518-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01518-5","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"C.G. reports personal fees from Novartis, Teva and Lilly.R.D.I. reports no disclosures.D.W.D reports competing interests for consulting: Amgen, Allergan, Abbvie, Lundbeck, Biohaven, Pfizer, Atria Health, CapiThera Ltd., Cerecin, Cooltech, Ceruvia Lifesciences LLC, Ctrl M, Allergan, Biohaven, GSK, Lundbeck, Eli Lilly, Novartis, Impel, Salvia, Satsuma, Theranica, WL Gore, Nocira, Perfood, Praxis, AYYA Biosciences, Revance. Payment or honoraria for lectures, presentations, educational events: Amgen, Novartis, Eli Lilly, Teva, Allergan, Abbvie, Lundbeck, Biohaven, Pfizer. Participation on a Data Safety Monitoring Board or Advisory Board: Amgen, Novartis, Eli Lilly, Allergan, Abbvie, Lundbeck, Biohaven Honoraria: Vector psychometric Group, Clinical Care Solutions, CME Outfitters, Curry Rockefeller Group, DeepBench, Global Access Meetings, KLJ Associates, Academy for Continued Healthcare Learning, Majallin LLC, Medlogix Communications, MJH Lifesciences, Miller Medical Communications, WebMD Health\/Medscape, Wolters Kluwer, Oxford University Press, Cambridge University Press. Research Support: Department of Defense, National Institutes of Health, Henry Jackson Foundation, Sperling Foundation, American Migraine Foundation, Patient Centered Outcomes Research Institute (PCORI). Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: American Migraine Foundation. American Brain Foundation. International Headache Society Global Patient Advocacy Coalition Stock Options\/Shareholder\/Patents\/Board of Directors: Aural analytics (options), ExSano (options), Man and Science (options), Healint (Options), Theranica (Options), Second Opinion\/Mobile Health (Options), Epien (Options\/Board), Nocira (options), Matterhorn (Shares\/Board), Ontologics (Shares\/Board), King-Devick Technologies (Options\/Board), Precon Health (Options\/Board), AYYA Biosciences (Options), Atria Health (options). Patent 17189376.1\u20131466:vTitle: Botulinum Toxin Dosage Regimen for Chronic Migraine Prophylaxis (Non-royalty bearing). Patent application submitted: Synaquell (Precon Health).H.A. reports personal fees from Teva.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}